Principles and Importance
Unethical healthcare services marketing affects corporate credibility in the long term. Related stakeholders such as patients who receive false marketing information will lose their trust in BDMS shareholders. Therefore, BDMS is committed to introduce transparent marketing, sales and labeling practices in conformity with regulations to ensure that the patients are informed of authenticated information on medication and treatments according to their needs.
Marketing Communication, Sales Practices and Drug Labeling
BDMS Marketing and Pharmacy Department are responsible for the marketing training and communication as well as sales practices and Drug labeling as stated by in the Notifications of the Department of Health Service Support, the Notifications of Central Committee on Prices of Goods and Services, the Ministry of Public Health and the Drug Act. Besides, various communication channels have been introduced to stakeholders to report any misconduct.